Podcast Episodes

Back to Search
Highlights in MDS at ASH 2022: Treating lower-risk & higher-risk disease, trial updates, & more

Episode 176

The 64th American Society of Hematology (ASH) Annual Meeting and Exposition took place on December 10-13, 2022, in New Orleans, LA, and saw leading e…

3 years, 9 months ago

Short Long
View Episode
iwNHL Session V: novel therapies in NHL – the role of ADCs

The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in the fiel…

3 years, 9 months ago

Short Long
View Episode
iwNHL Session V: Novel therapies in NHL - the role of ADCs

Episode 175

The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in the fiel…

3 years, 9 months ago

Short Long
View Episode
iwAL 2022 Session V: mechanisms of resistance to targeted therapies in AML

The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the field as they d…

3 years, 9 months ago

Short Long
View Episode
iwAL 2022 Session V: Mechanisms of resistance to targeted therapies in AML

Episode 174

The 4th International Workshop on Acute Leukemias (iwAL) 2022 took place in Nice, France, and brought together leading experts in the field as they d…

3 years, 9 months ago

Short Long
View Episode
The importance of genomic testing in CLL and its role in clinical decision-making

Chronic lymphocytic leukemia (CLL) remains a challenging hematological malignancy to treat, and genomic testing has become increasingly important in …

3 years, 10 months ago

Short Long
View Episode
The importance of genomic testing in CLL and its role in clinical decision-making

Episode 173

Chronic lymphocytic leukemia (CLL) remains a challenging hematological malignancy to treat, and genomic testing has become increasingly important in …

3 years, 10 months ago

Short Long
View Episode
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells

The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in the fiel…

3 years, 10 months ago

Short Long
View Episode
iwNHL Session IV: T-cell therapies for NHL: CAR-T therapies & third-party EBV T-cells

Episode 172

The 19th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2022 took place in Barcelona, Spain, and brought together leading experts in the fiel…

3 years, 10 months ago

Short Long
View Episode
Key updates in CLL: novel treatment strategies, the changing role of chemotherapy, and more

The treatment landscape of chronic lymphocytic leukemia (CLL) has transformed over the years with the increased use of Bruton’s tyrosine kinase (BTK)…

3 years, 10 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us